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Environmentally Induced Cardiovascular
Malformations
The NIEHS invites applications to study environ-
mental agents that cause cardiovascular malformations
(CVMs). The purposes of this PA are to stimulate
research to characterize environmental agents that
cause alterations in the development of the cardiovas-
cular system and thereby lead to CVMs, and to inves-
tigate the cellular and molecular mechanisms involved
in the development of these CVMs. The use of mam-
malian and nonmammalian animal models, including
transgenic and gene knockout animal models, and of
state-of-the-art molecular biology techniques such as
genomics and proteomics is encouraged, as well as
collaborations between environmental health scien-
tists and developmental biologists, to develop research
programs to address the high rate of CVMs.
CVMs are the most common type of birth defect
among live births in the United States, occurring in
approximately 0.8% of live births. The most common
types of CVMs include atrial or ventricular septal
defects, transposition of the great vessels, persistent
truncus arteriosus, teratology of Fallot, and coarcta-
tions. Despite the importance of these in malforma-
tions, in terms both of human suffering and cost to
the health care system, the causes of most cases of
CVMs are not known. 
Etiologic factors that have been identified
include genetics, maternal diseases such as diabetes,
certain drugs such as phenytoin and cocaine, and
dietary factors such as folic acid deficiency, vitamin A
excess, and copper deficiency. In addition, certain
environmental chemicals have been shown to be asso-
ciated with cardiac malformations. For instance, in
one large epidemiologic study of cardiac malforma-
tions, the Baltimore–Washington Infant Study, expo-
sure to such environmental factors as paints, solvents,
degreasers, and pesticides was associated with
increased cardiac malformations. 
Epidemiologic studies have also reported CVM
associations with air pollutants (ozone and carbon
monoxide) and trichloroethylene (TCE). In addition,
environmental contaminants such as TCE, bis-
diamine, and dioxin have been shown to be cardiac
teratogens in animal studies.
Despite the evidence for an environmental role
in CVMs, the list of environmental agents tested for
teratogenic effects on the heart is limited, and relative-
ly little research has been done on the cellular and
molecular basis of the teratogenic effects of environ-
mental agents or on the possible interactions between
environmental exposures and other factors such as
diet and genetics. Recent advances in genomic and
molecular biology technology and in the understand-
ing of the development of the fetal heart make this an
opportune time to initiate such studies.
Specific areas of interest to the NIEHS include,
but are not limited to, the following: 1) characteriza-
tion of new potential environmental cardioteratogens
that would include the types of CVMs induced,
dose–response evaluation, identification of specific
windows of vulnerability to the agent, and develop-
ment of preliminary data for further mechanistic stud-
ies; 2) use of forward and reverse mutagenesis studies
in model organisms to determine the genes altered by
specific cardiovascular developmental toxicants and
the relationship of the altered gene activity to
dysmorphogenesis; 3) characterization of global gene
expression profiles in the developing heart of model
organisms associated with the normal range of devel-
opment and after a developmentally toxic exposure
(the relationship between the changes in gene expres-
sion and the developmental lesion should be assessed);
4) use of genomic and/or proteomic profiling to
determine how well data on toxicant-induced malfor-
mations can be extrapolated across species; 5) identifi-
cation and evaluation of specific signal transduction
pathways and the associated genetic regulatory circuits
that might be sites of action of developmental cardio-
vascular toxicants (the causal relationships between
exposure and the CVMs should be developed); and 6)
determination of the potential for interactions
between exposures to environmental agents and
genetic susceptibility that increase the risk for cardio-
vascular developmental toxicity.
This PA will use the NIH R21 and R01 award
mechanism(s). Applications must be prepared using
the PHS 398 research grant application instructions
and forms (rev. 5/2001). The PHS 398 is available at
http://grants.nih.gov/grants/funding/phs398/phs398.
html in an interactive format. Applications submitted
in response to this PA will be accepted at the standard
application deadlines, which are indicated in the PHS
398 application kit. Complete information on this PA
is available at http://grants.nih.gov/grants/guide/
pa-files/PA-02-093.html.
Contact: J. Patrick Mastin, Scientific Program
Administrator, Organs and Systems Toxicology
Branch, Division of Extramural Research and
Training, NIEHS, PO Box 12233, EC-23, 111 T.W.
Alexander Drive, Research Triangle Park, NC 27709
USA, 919-541-3289, fax: 919-541-5064, e-mail:
mastin@niehs.nih.gov. Reference: PA No. PA-02-093
The Role of Gene–Environment Interactions
Underlying the Health Disparity of Premature
Birth
The National Institute of Child Health and Human
Development (NICHD), the National Institute of
Nursing Research (NINR), and the NIEHS are seek-
ing research grant applications on the role of
gene–environment interactions underlying the health
disparity of premature birth in the United States. The
major objective of this PA is to determine the role of
gene–environment interactions and genetic diversity
in the health disparity of premature birth. This PA
specifically addresses the need to better understand
how adverse societal, behavioral, and environmental
conditions alter gene expression and interact with
diverse genetic backgrounds to increase a woman’s
susceptibility for premature birth in high-risk racial
and ethnic groups in the United States. Furthermore,
the PA addresses the need for the identification and
functional characterization of genetic markers that
increase the risk of premature birth among these high-
risk populations. Multidisciplinary applications link-
ing biomedical scientists with social and behavioral
scientists are highly encouraged.
This PA seeks research projects focused on one or
more of the following goals: 
1) Determine changes in gene or protein expres-
sion under adverse societal, behavioral, or environ-
mental conditions to identify candidate genes or their
corresponding proteins that may be involved in
increasing a woman’s susceptibility for premature
delivery in high-risk racial and ethnic populations in
the United States. Examples include, but are not lim-
ited to, studies utilizing gene or protein expression
profiling by high-throughput platforms, such as DNA
arrays, protein arrays, and protein capture/SELDI-
TOF mass spectrometry.
2) Determine the functional relevance of an
identified gene or protein for increasing a woman’s
susceptibility for premature delivery under adverse
societal, behavioral, or environmental conditions in
high-risk racial and ethnic populations in the United
States. Examples include, but are not limited to, stud-
ies elucidating the function or mechanism of action of
an identified gene or protein in precipitating prema-
ture delivery.
3) Determine genomic differences that serve as
potential candidate markers for increasing a woman’s
susceptibility for premature delivery under adverse
societal, behavioral, or environmental conditions in
high-risk racial and ethnic populations in the United
States. Examples include, but are not limited to, link-
age studies using high-throughput genotyping plat-
forms to uncover genomic differences, such as
sequence repeats and multiple or single nucleotide
polymorphisms.
4) Determine the functional relevance of candi-
date genomic markers associated with an increased
risk for premature birth in high-risk racial and ethnic
populations in the United States. Examples include,
but are not limited to, studies that determine the
functional consequence of these markers as it relates
to gene expression, function, or regulation.
Applicants are encouraged to consider the com-
plexity of issues surrounding the meaning and assess-
ment of race and ethnicity, because an individual’s
identification with a particular racial or ethnic group
may involve not only an individual’s genetic back-
ground but also his or her cultural and geographical
identity. As appropriate for their particular propos-
als, applicants should consider the degree of genomic
heterogeneity within racial and ethnic populations
and that genetic differences may not apply broadly
to a specific race or ethnic group, and should consid-
er the new Office of Management and Budget
(OMB) directives on classifying race and ethnicity.
NIH policy on reporting race and ethnicity data
based on OMB directives is available at
http://grants.nih.gov/grants/guide/
notice-files/NOT-OD-01-053.html.
Because the NIEHS has expanded its research
agenda through the Environmental Genome Project,
the NIEHS is particularly interested in applications
that examine the complex interplay of genes and the
environment. The understanding of the critical role of
genetic susceptibility and sensitivity to environmental
exposures will lead to more effective disease preven-
tion and improved public health.
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This PA will use the NIH research project grant
(R01) award mechanism. Applications must be pre-
pared using the PHS 398 research grant application
instructions and forms (rev. 5/2001). The PHS 398 is
available  at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format.
Applications submitted in response to this PA will be
accepted at the standard application deadlines indicat-
ed in the PHS 398 application kit. Complete infor-
mation on this PA is available at http://
grants.nih.gov/grants/guide/pa-files/PA-02-102.html.
Contact: John V. Ilekis, Pregnancy and
Perinatology Branch, NICHD, 6100 Executive
Boulevard, Room 4B03, MSC 7510, Bethesda, MD
20892-7510 USA, 301-435-6895, fax: 301-496-
3790, e-mail: ilekisj@mail.nih.gov; Yvonne Bryan,
Division of Extramural Activities, NINR, 45 Center
Drive, Room 3AN-12, MSC 6300, Bethesda, MD
20892-6300 USA, 301-594-6908, fax: 301-480-
8260, e-mail: yvonne_bryan@nih.gov; Kimberly Gray
Kamins, Chemical Exposures and Molecular Biology
Branch, NIEHS, PO Box 12233, EC-21, 111 T.W.
Alexander Drive, Research Triangle Park, NC 27709
USA, 919-541-0293, fax: 919-316-4606, e-mail:
gray6@niehs.nih.gov. Reference: PA No. PA-02-102
Centers for Population Health and Health
Disparities
The purpose of the Centers for Population Health
and Health Disparities (CPHHD) is to support
interdisciplinary research leading to an understand-
ing and reduction of health disparities in domestic
populations. Applicants are invited to propose multi-
level, integrated research projects that will elucidate
the complex interactions of the social and physical
environment, mediating behavioral factors, and bio-
logic pathways that determine health and disease.
The CPHHD is expected to create an environment
conducive to interdisciplinary and reciprocally bene-
ficial collaborations among biomedical scientists,
social scientists, and affected communities, with the
common goal of improving population health and
reducing health disparities.
This is a trans-NIH request for applications
(RFA) sponsored jointly by the NIEHS, the National
Cancer Institute (NCI), the National Institute on
Aging (NIA), and the Office of Behavioral and Social
Science Research. Applicants are encouraged to pro-
pose research across disease outcomes or health-related
issues relevant for these institutes.
To achieve this goal, the CPHHD will sup-
port three or more thematically linked research
projects, facility cores that support two or more
projects, an administrative core, and pilot projects.
The CPHHD will present opportunities to con-
currently study biological, behavioral, psychologi-
cal, cultural, and social precursors of disease.
A key objective is to generate a research pro-
gram that embraces the concept of multiple levels
of analysis in health sciences to examine factors
operating at the social/environmental, behavioral/
psychological, and biological (organ system, cellu-
lar, and molecular) levels. Centers should propose
mechanistic and intervention studies across multi-
ple levels of analysis and across diseases and condi-
tions relevant to the mission of the sponsoring
institutes.
The theme of a proposed CPHHD research
project may be organized to examine a) a single
condition for which a significant disparity in
morbidity and/or mortality between populations
has been demonstrated (e.g., obesity, infant mor-
tality, low birth weight, diabetes, CHD, asthma,
cancer), its relationship to multiple social and
physical environmental determinants, and their
mechanistic pathways; or b) a particular category
of social environmental determinant (e.g., food
supply, urban crowding, built environment,
social support) and mechanistic pathways by
which it affects multiple health outcomes for
which disparities have been demonstrated
between populations.
This RFA supports research across multiple
levels of analysis. Applicants must develop a the-
matic focus that can be carried across
population(s), behavior, and biologic pathways for
the diseases or conditions under study. At least two
of the following levels must be addressed in pro-
posed research projects.
Examples of activities relevant to the spon-
soring institutes include but are not limited to 1)
examining differential social gradients for specific
cancer sites and the contribution of known risk
factors to these gradients; 2) identifying and elu-
cidating pathways by which the built environ-
ment exerts influence on persons with functional
disabilities and on diverse health outcomes such
as infant morbidity and mortality, asthma, per-
turbations of the immune system, degenerative or
developmental neurologic disorders, cognitive
disorders, behavioral disorders, sensory impair-
ment, and cardiovascular disease; 3) elucidating
the role of the social and physical environments
and behavioral and biologic pathways in explain-
ing the persistent disparities in cervical cancer
mortality; 4) evaluating whether social class or
other social factors affect the availability and effi-
cacy of therapeutic interventions for diseases such
as sickle cell disease that predominately affect
specific population subgroups; 5) increasing
emphasis on the collection of biomarkers in epi-
demiologic studies of social relationships and
health; 6) examining the consequences of retire-
ment on health and functioning; and 7) characteriz-
ing differentials in income and wealth accumulation
for subpopulations (such as elderly, racial and eth-
nic minorities, preretirement workers) and identify-
ing the sources of these differentials and their
impacts on health status.
Support of this program will be through the
P50 Specialized Centers Grant. The anticipated
award date is 1 April 2003.
The sponsoring institutes intend to commit
approximately $15 million (NIEHS $5 million,
NCI $8 million, and NIA $2 million) in fiscal year
2003 to fund seven or eight new grants in response
to this RFA. An applicant may request a project
period of up to 5 years and a budget for direct
costs of up to $1.3 million per year.
The deadline for receipt of applications is 29
July 2002. Complete information on this RFA is
available online at http://grants1.nih.gov/grants/
guide/rfa-files/RFA-ES-02-009.html.
Contact: Suzanne Heurtin-Roberts, NCI,
Division of Cancer Control and Population
Sciences, 6130 Executive Boulevard, EPN 4054,
Bethesda, MD 20892 USA, 301-594-6655, fax:
301-435-7547, e-mail: sheurtin@mail.nih.gov;
Frederick L. Tyson, Chemical Exposures and
Molecular Biology Branch, NIEHS, PO Box
12233, 111 T.W. Alexander Drive, EC-21,
Research Triangle Park, NC 27709 USA, 919-
541-0176, fax: 919-316-4606, e-mail: tyson2@
niehs.nih.gov; Georgeanne E. Patmios, NIA,
Behavioral and Social Research Program, 7201
Wisconsin Avenue, Gateway Building, Suite 533,
Bethesda, MD 20892-7936 USA, 301-496-3138,
fax: 301-402-0051, e-mail: patmios@nih.gov.
Reference: RFA No. RFA: ES-02-009
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